Pomalidomide Plus Dexamethasone (Pd) In The Treatment Of Asian Patients With Relapsed/Refractory Myeloma (Rrmm) Who Are Previously Treated With Bortezomib And Refractory To Lenalidomide - Interim Analysis Of A Trial By The Asian Myeloma Network (Amn)
BLOOD（2016）
摘要
Background
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要